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Abstract
Background: Microglia-derived lysosomal cathepsins are important inflammatory mediators to trigger signaling
pathways in inflammation-related cascades. Our previous study showed that the expression of cathepsin C (CatC) in
the brain is induced predominantly in activated microglia in neuroinflammation. Moreover, CatC can induce
chemokine production in brain inflammatory processes. In vitro studies further confirmed that CatC is secreted
extracellularly from LPS-treated microglia. However, the mechanisms of CatC affecting neuroinflammatory responses
are not known yet.
Methods: CatC over-expression (CatCOE) and knock-down (CatCKD) mice were treated with intraperitoneal and
intracerebroventricular LPS injection. Morris water maze (MWM) test was used to assess the ability of learning and
memory. Cytokine expression in vivo was detected by in situ hybridization, quantitative PCR, and ELISA. In vitro,
microglia M1 polarization was determined by quantitative PCR. Intracellular Ca2+ concentration was determined by
flow cytometry, and the expression of NR2B, PKC, p38, IkBα, and p65 was determined by western blotting.
Results: The LPS-treated CatCOE mice exhibited significantly increased escape latency compared with similarly
treated wild-type or CatCKD mice. The highest levels of TNF-α, IL-1β, and other M1 markers (IL-6, CD86, CD16, and
CD32) were found in the brain or serum of LPS-treated CatCOE mice, and the lowest levels were detected in
CatCKD mice. Similar results were found in LPS-treated microglia derived from CatC differentially expressing mice or
in CatC-treated microglia from wild-type mice. Furthermore, the expression of NR2B mRNA, phosphorylation of
NR2B, Ca2+ concentration, phosphorylation of PKC, p38, IκBα, and p65 were all increased in CatC-treated microglia,
while addition of E-64 and MK-801 reversed the phosphorylation of above molecules.
Conclusion: The data suggest that CatC promotes microglia M1 polarization and aggravates neuroinflammation via
activation of Ca2+-dependent PKC/p38MAPK/NF-κB pathway. CatC may be one of key molecular targets for
alleviating and controlling neuroinflammation in neurological diseases.
Keywords: Neuroinflammation, Microglia, Cathepsin C, Cytokine, NR2B
* Correspondence: 2286130554@qq.com; ma_jianmei@hotmail.com
†Qing Liu and Yanli Zhang contributed equally to this work.
1Department of Anatomy, Dalian Medical University, West Section No.9,
South Road, Lvshun, Dalian 116044, Liaoning, China
Full list of author information is available at the end of the article
© The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Liu et al. Journal of Neuroinflammation           (2019) 16:10 
https://doi.org/10.1186/s12974-019-1398-3
Introduction
Cysteine cathepsins have been viewed as enzymes
involved in final protein degradation in the lysosomes.
Recently, evidence from numerous studies has demon-
strated that some cathepsins, such as cathepsin B, L, S, H,
and X, play important roles in health or disease condition
in the central nervous system (CNS) [1–6].
Cathepsin C (CatC), also known as dipeptidyl peptid-
ase I, is a cysteine exopeptidase that is expressed in
many types of cells. CatC functions as a key enzyme in
the activation of granule serine proteases in cytotoxic T
lymphocytes, natural killer cells (granzymes A and B),
mast cells (chymase and tryptase), and neutrophils (ca-
thepsin G, proteinase 3, and elastase) through removing
N-terminal pro-dipeptides from the zymogen forms of
these proteases [7–9]. The roles of CatC in modulating
the inflammatory responses have been assessed in a
number of animal models of inflammation. It has been
found that CatC knockout mice are completely resistant
to the acute arthritis and showed a high degree of pro-
tection in a collagen-induced rheumatoid arthritis model
[10, 11]. In addition, the inflammatory cell infiltration and
proinflammatory cytokine production have been shown to
be decreased in CatC knockout mouse models of asthma,
chronic obstructive pulmonary disease (COPD), sepsis,
and abdominal aortic aneurysms [12–15]. Thus, CatC has
been considered as a potential pharmacological target in
inflammation therapy [16].
More recently, CatC expression is found in the normal
brain in a region-dependent manner, and granular immu-
noreactive signals mainly exist in neuronal perikarya of
particular brain regions, including the accessory olfactory
bulb, the septum, CA2 of the hippocampus, a part of the
cerebral cortex, the medial geniculate, and the inferior col-
liculus [17, 18]. In different pathological conditions, the
expression of CatC is upregulated dramatically and dis-
tributed widely in the brain, for instance, strong expres-
sion of CatC is found in peri-damaged portions of
hypoxic-ischemic injury [18], in the whole brain of intra-
peritoneally injected LPS-induced neuroinflammation
[17], and in demyelinating areas in the cuprizone-induced
demyelination model [19]. The cellular localization ana-
lysis in our previous study shows that CatC is induced
predominantly in activated microglia (MG) in neuroin-
flammation. In vitro study further reveals the inducers of
microglial CatC expression and secretion could be LPS or
proinflammatory factors such as interleukin-1β (IL-1β)
and IL-6 stimulation [17]. On the other hand, our previ-
ous study also found that CatC can induce glia-derived
chemokine (CXCL2) production, which may attract in-
flammatory cells to sites of myelin sheath damage in a
cuprizone model [19]. These lines of evidence suggest that
CatC is involved in regulation of normal neuronal func-
tions in certain brain regions, and more importantly,
participates in inflammatory processes accompanying
pathogenesis in the CNS. Herias et al. [20] reported that
CatC may exert immunomodulatory effects on macro-
phages and pointed that there is an autocrine feedback of
CatC in macrophage polarization towards M1 in athero-
sclerotic lesion. Our previous study has found that CatC is
secreted extracellularly from MG following LPS stimula-
tion [17]. Furthermore, the enzymatic activity of extracel-
lular CatC is upregulated by the treatment of LPS, IL-6,
and IL-1β. These findings implicate that secreted CatC
may play functionally significant roles extracellularly.
Neuroinflammation is now recognized as a key feature
in the pathogenesis of neurodegenerative diseases and
neuropsychiatric disorders [21, 22]. Microglia as the
principle immune cells in the CNS are activated and re-
lease inflammatory mediators capable of provoking neu-
roinflammation. The overactivation of microglia has
been implicated in loss of memory, cognitive deficit, and
behavioral impairments of many neurological diseases
[22–26]. However, whether and how CatC impacts on
microglial activation and inflammatory responses, fur-
ther causes diminished cognition and memory, namely,
the functional roles of CatC and possible molecular
mechanisms in inflammation-associated brain diseases is
not known yet.
In the present study, the effects of CatC on neuroin-
flammation was first investigated in intraperitoneal (i.p.)
and intracerebroventricular (i.c.v.) LPS injection model
by using conditional CatC over-expression (CatCOE)
and knock-down (CatCKD) transgenic mice, and pos-
sible mechanisms involved were further studied by in
vitro experiments. We found that CatC aggravates neu-
roinflammation by promoting MG polarization towards
M1 phenotype, and this effect is mainly achieved
through activation of Ca2+-dependent PKC/p38 MAPK/
NF-κB pathway which is triggered by glutamate receptor
subunit NR2B. Our study may have implications for the
prevention and the treatment of inflammation-related
neurological disorders.
Material and method
Animals
Adult C57BL/6 mice were obtained from Dalian Medical
University Animal Center. CatC STOP-tetO mice (CatC
STOP-tetO/+; C57BL/6 background), and Iba1-tTA
mouse line 75 (initial BDF1 background backcrossed to
C57BL/6 background) were kindly provided by Professor
Ikenaka [27]. CatC down-expression (CatCSTOP-tetO/S-
TOP-tetO; CatCKD) was achieved by generation of
STOP-tetO knockin mice in which CatC expression was
blocked in hippocampal CA2 neurons and other cells
in vivo. CatC over-expression (CatCSTOP-tetO/
STOP-tetO::Iba1-tTA; CatCOE) was achieved by crossing
STOP-tetO knockin mice with the microglia-selective
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tTA-expressing line Iba1-tTA; thus, CatC expression was
restricted in Iba-1 positive cells, not in neurons.
Adult animals (8–9 weeks) weighing 20–25 g were
housed in groups of five per cage with regular light/dark
cycles (lights on at 8:00 a.m., lights off at 8:00 p.m.)
under controlled temperature (22 ± 2 °C) and humidity
(50 ± 10%), and were given standard diet and water ad
libitum. All experiments were carried out in strict ac-
cordance with the requirements of Dalian Medical Uni-
versity guidelines for the proper care and use of
laboratory animals and were approved by the Laboratory
Animal Care and Use Committee of Dalian Medical
University.
Intracerebroventricular (i.c.v.) injection
LPS (Escherichia coli, serotype 055:B5, Sigma-Aldrich
Chemical Corp., St. Louis, MO, USA) and active CatC
(R&D, MN, USA) were used in the experiment. Mice were
anesthesized with intraperitoneal (i.p.) injection of tribro-
moethanol (0.2ml/10 g body weight), and the skull surface
was cleaned with polyvidone iodine solution. Then mice
were fixed to a stereotaxic apparatus (Stoelting Company,
Wood Dale, IL, USA) and received right-unilateral injec-
tion of LPS (1mg/kg) or CatC (100 ng/kg) in a volume of
2 μl. Control mice were treated with 0.9% saline vehicle in
the same volume. The following coordinates were used for
central injection: 0.25mm posterior, 1.0 mm right lateral,
and 2.5 mm dorsoventral to bregma.
Morris water maze (MWM) test
Eight-week-old mice were randomly divided into con-
trol, wild type (WT), CatCOE, and CatCKD groups.
Mice were administrated of LPS (100 μg/kg, i.p.).
MWM test was performed for assessment of spatial
learning and memory ability as described previously
[28]. The equipment included a white pool (150 cm
diameter, 35 cm deep) that was filled with opaque
water at approximately 22 ± 1 °C which was divided
into four quadrants of equal area. An escape platform
(8 cm in diameter) was placed 1 cm below the surface
of the water. Geometric objects with contrasting
colors and shapes were set on the wall of the water
tank. Mice were trained 3 times a day at 20-min in-
tervals for 5 consecutive days. In each trial, mice
were given 90 s to find the platform. If the mice did
not locate the platform within the maximum time, it
was guided to the platform and allowed to remain
there for 10 s. Swimming was recorded by video
(AnyMaze; Stoelting Co., Wood Dale, IL, USA) above
the pool. Swimming speed, the escape latency, and
the number of crossings over the platform location
were analyzed and plotted.
Tissue preparation
Mice were anesthesized by injection of tribromoethanol
(0.2 ml/10 g, i.p.) and transcardially perfused with 4%
paraformaldehyde. Brains were stored in 20% sucrose so-
lution. Serial 18 μm sagittal sections were prepared by
the cryostat microtome (Leica CM 3050 S, Leica Micro-
systems AG, Wetzlar, Germany) and the samples were
stored at − 80 °C until biochemical estimations.
Immunohistochemical staining
Immunohistochemical (IHC) staining was performed as
described by Ma et al. [29]. Antigen retrieval was per-
formed, and sections were blocked with 1% bovine
serum albumin (BSA) for 20 min, then incubated with
primary rabbit anti-Iba1 polyclonal antibody (1:500,
Wako, Osaka, Japan, catalog number 019-19741) at 4 °C
overnight, secondary biotinylated IgG antibody (1:200,
Vector Laboratories Inc., Burlingame, CA, USA) for 2 h
at room temperature. Images were taken with the Nikon
digital camera system (DS-Fi1) in combination with mi-
croscopy (Nikon eclipse 80i).
In situ hybridization
In situ hybridization (ISH) was carried out as our previous
description [17]. Briefly, 18-μm-thick frozen brain sections
were fixed in 4% PFA for 15min at room temperature.
After equilibration in hybridization buffer (50% formam-
ide, 5 × SSC, 40mg/ml salmon sperm DNA), sections
were hybridized with the Digoxigenin (DIG)-labeled
TNF-α (NM_013693.2, 575-1607 bp) cRNA probes in
hybridization buffer overnight at 60 °C. After washing and
antigen blocking, the sections were incubated with alka-
line phosphatase-conjugated anti-DIG antibody (Roche,
Basel, Switzerland) at room temperature 2 h. For color de-
velopment, 4-nitro blue tetrazolium chloride (NBT)
(Roche Diagnostic Gmbh, Mannheim, Germany) and
5-bromo-4-chloro-3-indolyl-phosphate (BCIP) (Roche
Diagnostic Gmbh, Mannheim, Germany) were incubated
for 8 h at room temperature. Images of the stained sec-
tions were taken by Nikon digital camera system (DS-Fi1,
Nikon Corp., Tokyo, Japan) in combination with micros-
copy (Nikon Eclipse 80i).
Microglia culture
Primary microglia culture was performed as described
by Fan et al. [17]. Postnatal 1–2 day mouse brains were
dissected and stripped of meninges, then were
aseptically dissociated into single cell suspension and
seeded in 10 cm culture dish with 10% fetal bovine
serum (FBS) (ICN Biomedicals, Aurora, OH, USA) in
Dulbecco’s modified Eagle’s medium (DMEM) (Sigma).
At the 3rd and 10th day, the culture medium was chan-
ged. After 13–14 days, detached microglia were col-
lected and plated on 6-well plates at an appropriate
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density and cultured at 37 °C (5% CO2, 95% humidity).
Murine BV2 cell line was cultured in DMEM supple-
mented with 10% FBS, penicillin (100 U/ml), and
streptomycin (100 mg/ml), and maintained at 37 °C in a
humidified incubator with 5% CO2. Cells were
sub-cultured when reaching 90% confluence.
Quantitative real-time PCR (qRT-PCR)
Total RNA was extracted from brain tissue and primary
microglia using TRlzol reagent (Life Technologies, USA)
in accordance with manufacturer’s instructions. RNA con-
centration and purity were assessed using OD260 and
OD260/OD280 ratio (Nanodrop 2000, Thermo Scientific,
USA), respectively. PrimeScriptTM RT reagent kit
(Takara, DRR037A) was used for cDNA production.
qRT-PCR was performed using SYBR Premix Ex Taq II
(TaKaRa, RR820A) containing 2 μl cDNA, 10 μl SYBR
green PCR Master Mix, 0.2 μM forward primer, 0.2 μM re-
verse primer, and 6 μl RNAse free water in a final volume
of 20 μl and analyzed with Stratagene Mx3000p (Agilent-
Technologies, Santa Clara, CA, USA).The thermal cycling
parameters of q-PCR includes 95 °C 10min,1 cycle; 95 °C
15 s, 60 °C 30 s,71 °C 45 s, 40 cycles. β-actin was used as
the internal standard reference, and normalized expres-
sions of targeted genes were calculated using the compara-
tive CT method and fold changes were calculated using
the 2−ΔΔCt method [30]. All primers used in this study are
designed by Takara Bio Inc., China and listed in Table 1.
Enzyme-linked immunosorbent assay (ELISA)
Blood samples were collected after MWM test and cen-
trifuged at 2000×g for 20 min to obtain serum samples.
Microglia culture medium was collected 24 h after LPS
stimulation. Proteins from brains and primary cultured
microglia were extracted using RIPA lysis buffer (Keygen
Biotech. Co., LTD, Nanjing, China), and concentrations
of protein were determined by the BCA Protein Assay
Kit (Keygen Biotech. Co., LTD, Nanjing, China). All
samples were stored at − 80 °C before assay. Detection of
TNF-α, IL-1β, IL-6, and IFN-γ was performed by corre-
sponding ELISA Development Kits (Peprotech, Rehovot,
Israel) in accordance with the manufacturer’s instruc-
tions. Monitor color development with an ELISA plate
reader (iMark, Bio-rad, Japan) at 405 nm with wave-
length correction set at 650 nm.
Flow cytometry analysis
Primary microglia were seeded at a density of 1 × 106
cells/ml and starved with DMEM with 2% FBS overnight.
After being treated with 100 ng/ml CatC for 18 h, the
single-cell suspension was harvested followed by centrifu-
gation at 300×g for 5min at 4 °C. After washing and
blocking with Fc Block CD16/CD32 (1:100, R&D, MN,
USA) for 30min on ice, cells were incubated for 45min in
the dark room with the followed antibodies:
APC-conjugated anti-Rat CD206 (10 μl/106 cells; R&D,
MN, USA), FITC-conjugated anti-mouse CD86 (0.125 μg/
test; eBioscience, Waltham, MA, USA). Finally, the cells
were resuspended in 500 μl PBS and subjected to FACS-
Caliber flow cytometry (BD, Franklin Lakes, USA). The
data were analyzed by the Cell-Quest data analysis soft-
ware (10,000 events per sample; BD, Franklin Lakes,
USA). Negative isotypes were used for gating. The per-
centages of positive and negative cells were measured.
Immunofluorescent staining
Primary cultured microglia were seeded on glass cover
slips and treated with 100 ng/ml CatC (R&D, MN, USA)
Table 1 Primer sequences used for RT-PCR analysis
Gene Primer
Forward Reverse
TNF-α ATCCGCGACGTGGAACTG ACCGCCTGGAGTTCTGGAA
IL-1β GAGCACCTTCTTTTCCTTCATCTT TCACACACCAGCAGGTTATCATC
IL-6 CAACGATGATGCACTTGCAGA CTCCAGGTAGCTATGGTACTCCAGA
iNOS TAGGCAGAGATTGGAGGCCTTG GGGTTGTTGCTGAACTTCCAGTC
CD16 GCCAATGGCTACTTCCACCAC GTCCAGTTTCACCACAGCCTTC
CD32 CCAGAAAGGCCAGGATCTAGTG GGGAACCAATCTCGTAGTGTCTGT
NR2B AGAACTTGGACGCTGTATTGGAGA TGCAACAGCCAAAGCTGGA
Ptk2 AGAACTTGGACGCTGTATTGGAGA TGCAACAGCCAAAGCTGGA
Ptger3 TGTGTGCTGTCCGTCTGTTG CTTCTCCTTTCCCATCTGTGTCTT
Slamf8 GTGCCAATTACACTGTTCCTGATCC GTCCAAGCACCAGTTTATGTTGTCC
Pex5l CCAACACTTTCATATCCGTTGCTC CTGCCTCTGGCATGGTTTCA
HPSE ACAAACGGAGTTGTTGAAGTGAGG AGCACTACAGACATCGGGACAGAG
β-actin TCATCACTATTGGCAACGACG AACAGTCCGCCTAGAAGCAC
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for 18 h. After being washed with PBS, cells were fixed
with 4% PFA for 20 min, then incubated with blocking
buffer (5% BSA and 0.1% Triton X-100; Gentihold,
Beijing, China) for 30 min, primary antibodies overnight
at 4 °C. Subsequently incubated with appropriate
fluorochrome-conjugated secondary antibodies and
4′,6-diamidino-2-phenylindole (DAPI, 1:1000; Sigma, St.
Louis, MO, USA) at room temperature for 1 h. Images
were captured by laser confocal microscopy (Leica,
Wetzlar, German). The following primary antibodies
were used: rabbit anti-CD86 (1:100, Abcam, Cambridge,
UK), goat anti-CatC (1:100; Abcam, Cambridge, UK).
The secondary antibodies were labeled with 488
Alexafluor (1:100; Abcam, Cambridge, UK), and 594
Alexafluore (1:100; Proteintech, Wuhan, China).
Western blot analysis
After primary cultured microglia and BV2 cells were
treated with active CatC (100 ng/ml) alone for 12 h, or
co-stimulated with E-64 (10μΜ), an inhibitor of cysteine
peptidases and pre-treated MK-801 (50 μM), an antagon-
ist of the N-Methyl-D-aspartate (NMDA) receptor for 1
h, the total protein was extracted using RIPA lysis buffer
(KeyGEN, Nanjing, China) containing protease inhibi-
tors (PMSF, 1:100; Biosharp, Hefei, China) and phos-
phatase inhibitor cocktail (1:100; MedChem Express,
Shanghai, China). The protein concentration was deter-
mined by BCA Protein Assay Kit (KeyGEN, Nanjing,
China), and 30 μg protein was denatured in 4×sample
buffer at 95 °C for 5 min, and then loaded per lane. Then
equal amount of protein samples was resolved on
SDS-PAGE and transferred to nitrocellulose membrane
(NC; Pall Corporation, Mexico). The NC membranes
were blocked with 5% BSA before incubation overnight
with the appropriate primary antibody at 4 °C. After hav-
ing been washed three times for 10 min with
tris-buffered saline-Tween-20 buffer (TBST), the NC
membranes were incubated with fluorescence labeling
secondary antibody (1:15000; LI-COR Biosciences,
Lincoln, NE, USA) in 60min at room temperature. Im-
ages were captured and quantified by Odyssey CLx
Imager and Image Studio software (LI-COR Biosciences,
Lincoln, NE, USA).The following primary antibodies
were used: rabbit anti-NMDA (1:500; Abcam,
Cambridge, UK); rabbit anti-phospho-NMDA (1:500;
Cell Signaling Technology, Danvers, MA, USA); rabbit
anti-phospho-PKC (1:500; Cell Signaling Technology,
Danvers, MA, USA); rabbit anti-PKC (1:500; Cell Signal-
ing Technology, Danvers, MA, USA); mouse anti-p38
(1:500; Proteintech, Wuhan, China), rabbit anti-phos-
pho-p38 (1:500; Cell Signaling Technology, USA), rabbit
anti-phospho-IκBα (1:500; Cell Signaling Technology,
Danvers, MA, USA), mouse anti-IκBα (1:500; Cell Sig-
naling Technology, Danvers, MA, USA); rabbit anti-
phospho-NF-κB p65 (1:500; Cell Signaling Technology,
Danvers, MA, USA); mouse anti-NF-κB p65 (1:500; Cell
Signaling Technology, Danvers, MA, USA); mouse
anti-GAPDH (1:5000; Proteintech, Wuhan, China).
Intracellular Ca2+ measurement
Fura-3-acetoxymethyl ester (Fluo-3 AM, Solarbio,
Beijing, China) was used to detect intracellular Ca2+
concentrations of microglia. Flow cytometry was per-
formed in accordance with the manufacturer’s instruc-
tions. After being treated with CatC (100 ng/ml), E-64
(10μΜ), or MK-801 (50 μM, pre-treatment for 1 h) for 6
h, microglia were resuspended in Hanks balanced salt
solution (HBSS) with Ca2+ and MgCl2 at 1 × 10
7 cells/
ml. The cells were incubated with 10 μM Fluo-3 AM in
(HBSS, KeyGEN, Nanjing, China) for 30 min at 37 °C.
Followed by centrifugation at 300×g for 5 min, microglia
were resuspended in 500 μl Ca2+ free-HBSS. The accu-
mulation of intracellular Ca2+ in individual cells was
measured by AccuriC6 (BD, Franklin Lakes, USA) at
506 nm of excitation wavelength. The data were analyzed
using the AccuriC6 analysis software.
Microarray hybridization and data analysis
The RNA sample of primary cultured microglia with or
without CatC stimulation was extracted by Trizol re-
agent (Life Technologies, USA). Then RNA quantity and
quality were measured by NanoDrop ND-1000, and
RNA integrity was assessed by standard denaturing agar-
ose gel electrophoresis. The Whole Mouse Genome
Oligo Microarray was generated for test and control
samples according to the Agilent One-Color
Microarray-Based Gene Expression Analysis protocol
(Agilent Technology). These profiles were generated
using customized 4 × 44 K oligonucleotide microarrays
produced by Agilent Technologies (Palo Alto, CA,
USA). The mouse whole genome microarrays covered
more than 41,000 genes and transcripts. The RNA sam-
ples were amplified and microarray hybridization was
performed in Agilent’s SureHyb Hybridization Chambers
using the Agilent Quick Amp labeling kit. After
hybridization and washing, the hybridized slides were
scanned using an Agilent DNA microarray scanner. The
microarray datasets were acquired in Agilent Feature
Extraction Software (v11.0.0.1) and normalized in
Agilent GeneSpring GX v12.1 Software which genes
marked as present were chosen for further analysis.
The procedure above was carried out by KangCheng
Bio-Tech, Shanghai, China.
Statistical analysis
All experimental data were analyzed using the SPSS Sta-
tistics software 19.0 (SPSS Inc., Chicago, IL, USA, 2006).
Repeated measures analysis of variance (ANOVA) was
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used to compare the escape latency among groups.
Other data were compared using one-way ANOVA. Data
are presented as means ± SEM. A value of P ≤ 0.05 was
considered significant.
Results
CatC aggravated LPS-induced impairments of spatial
learning and memory
LPS is derived from the cell wall of Gram-negative bac-
teria and is a potent endotoxin that causes the release of
cytokines such as interleukin-1 beta (IL-1β) and tumor
necrosis factor (TNF-α). Numerous reports have demon-
strated that neuroinflammation induced by a single in-
jection of LPS or IL-1β significantly impairs
hippocampal-dependent spatial learning memory by
inhibiting long-term potentiation (LTP), and this
impairment can be detected by Morris water maze
(MWM) analysis [31–33]. In our previous study, we have
demonstrated that CatC is only expressed in neurons in
some specific regions of normal brain, and CatC expres-
sion in MG could be induced by a single intraperitoneal
(i.p.) injection of LPS [17]. Therefore, in the present
study, we still used this model to clarify the functional
roles of CatC in the neuroinflammatory processes by
MWM analysis. First, we performed MWM analysis in
untreated CatCOE and CatCKD mice. The results
showed no significant differences between the untreated
WT, CatCOE, and CatCKD mice in place navigation test
(Fig. 1A (a, b)) or spatial probe test (Fig. 1B (a, b)), sug-
gesting that neither CatCOE nor CatCKD mice had
changes of learning and memory function. Next, we
treated another group of mice with a single injection of
Fig. 1 The effects of differential expression of CatC on learning and memory ability. MWM test was performed in the untreated WT, CatCOE, and
CatCKD mice. Place navigation test lasted for 5 days, and spatial probe test was performed on the sixth day. A Learning ability of untreated mice
was determined by the swimming speed (a) and escape latency (b) of place navigation test. B Memory ability of untreated mice was determined
by swimming speed (a) and escape latency (b) of spatial probe test. C LPS was injected after 5-day place navigation test as shown in time axis,
and spatial probe test was performed after 24 h later. D Memory ability of LPS-injected mice was determined by swimming speed (a), escape
latency (b), and crossing platform times (c) of spatial probe test. E Detection of learning ability of LPS-injected mice was illustrated in time axis.
F Learning ability of 5-day place navigation test was determined by the swimming speed (a), escape latency (b); the escape latency of the sixth
day is shown in c. The data represent mean ± SEM, n = 7–9. *P ≤ 0.05, ***P ≤ 0.001. *P ≤ 0.05, 2~5th days vs. 1st day in control, #P ≤ 0.05, WT + LPS
vs. CatCOE + LPS in Fig. 1F (b)
Liu et al. Journal of Neuroinflammation           (2019) 16:10 Page 6 of 18
LPS (100 μg/kg, i.p.) after 5 days navigation test, and WT
mice were treated with equivalent volume 0.9% saline as
the control, then the spatial probe test was performed
after 24 h of LPS administration (Fig. 1C). There were
no differences in swimming speed (Fig. 1D (a)), and only
CatCOE mice showed a significantly increased escape la-
tency (Fig. 1D (b)) and reduced crossing platform times
(Fig. 1D (c)), suggesting that CatCOE mice presented a
serious spatial memory impairment following LPS treat-
ment. Last, we pre-treated the third group of mice with
LPS injection (100 μg/kg, i.p.) before 24 h of the place
navigation test, then 5-day training and test were carried
to detect learning ability (Fig. 1E). All of LPS-treated
mice exhibited increased escape latency from the second
day compared with the control group (Fig. 1F (a, b)). On
the sixth day when learning training was finished, the es-
cape latency in all the LPS-treated mice was significantly
increased compared to control mice, and among LPS-
treated mice, CatCOE mice exhibited significantly in-
creased escape latency compared with that in wild-type or
CatCKD mice (Fig. 1F (c)), suggesting CatCOE aggravated
LPS-induced impairments of learning function. Taken to-
gether, the data indicate that CatC over-expression aggra-
vated LPS-induced impairments of spatial learning and
memory probably by exacerbating neuroinflammation.
CatC aggravated peripheral and central inflammatory
responses following a systemic injection of LPS
In order to investigate the effects of CatC on neuroin-
flammatory status, we detected the expression of CatC
in the wild-type, CatC OE, and CatC KD mice before
and after administration of LPS (100 μg/kg, i.p.). The
IHC staining results showed that CatC was predomin-
antly expressed in hippocampal CA2 neurons in un-
treated WT mice, while in the other brain areas CatC
expression was not detected (Fig. 2A). In CatC OE mice,
CatC expression in hippocampal CA2 neurons disap-
peared, instead, it scattered almost throughout the brain
(Fig. 2B). In contrast, no CatC-positive signals were
found in CatC KD mouse brain (Fig. 2C). This pattern
of CatC expression in transgenic mice confirmed the re-
liability of manipulation of CatC gene expression. Fur-
ther, 24 h after LPS injection, CatC expression was
increased in hippocampus and other brain areas in WT
and CatC OE mice (Fig. 2D, E), but more obviously
found in CatC OE mice. No CatC-positive signals were
found in Cat KD mice after LPS injection (Fig. 2F).
In order to investigate neuroinflammatory status in
CatC transgenic mice, MG activation and the expression
of TNF-α and IL-1β were detected by Iba-1 immunohis-
tochemical (IHC) staining, qRT-PCR, and ELISA. First,
we assessed MG in untreated WT, CatCOE, and
CatCKD mice. We found that the MG in the whole
brain including cortex and hippocampus in CatCOE
mice were slightly activated with slightly enlarged soma
and shortened processes, compared with that in the WT
and CatCKD mice (Fig. 3A). However, the expression of
proinflammatory factors TNF-α and IL-1β did not ex-
hibit significant differences among the WT, CatCOE,
and CatCKD mice at mRNA (Fig. 3B) or protein level
Fig. 2 The expression of CatC in the transgenic mouse brain before and after administration of LPS. WT, CatCOE, and CatCKD mice were
intraperitoneally injected with LPS (100 μg/kg) for 24 h before the brains were isolated. Immunohistochemical staining for CatC was performed on
the frozen brain sections. LPS induced CatC expression in WT (D) and CatCOE (E) mice, but not in CatCKD (F) mice. Scale bars, 100 μm
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(Fig. 3C) in the whole brain, indicating that CatC differ-
ential expression did not affect the immune equilibrium
in the brain in the condition of untreatment.
We next examined MG morphology and the expres-
sion of TNF-α, IL-1β in WT, CatCOE, and CatCKD
mice treated with LPS (100 μg/kg, i.p.). After treatment
for 24 h, mice were sacrificed, brains were removed, and
serum was collected. The Iba-1 IHC results showed sig-
nificantly activated MG with retracted processes, large
cell bodies and nuclei in all the LPS-treated mice.
Among them, more intensively activated patterns were
found in CatCOE mice but weaker in CatCKD mice
(Fig. 3D). Consistent with the activated status of MG,
the expression of TNF-α and IL-1β in the brain (Fig. 3E)
and serum (Fig. 3F) was significantly increased in the
LPS-treated mice, and among them, the highest level
was presented in CatCOE mice but lower levels in
CatCKD mice. These results indicate that CatCOE
Fig. 3 The effects of differential expression of CatC on microglia and proinflammatory cytokines in the brain. After spatial probe test, the
activation of microglia was detected by Iba1 IHC staining in cortex and hippocampus of untreated mice (A) and LPS (i.p.)-injected mice (D). The
levels of TNF-α and IL-1β were measured in untreated mice (B, C) and LPS-injected mice (E, F). The levels of TNF-α and IL-1β were determined by
qRT-PCR and ELISA. Scale bars, 100 μm (main panels), 25 μm (insets). *P ≤ 0.05, **P ≤ 0.01. n = 3 (A–D), n = 3–5 (E, F)
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aggravated LPS-induced inflammatory responses both in
peripheral blood and the CNS.
CatC aggravated neuroinflammation through
accentuating MG towards M1 polarization following a
central injection of LPS
The mechanisms by which circulating LPS is transmitted
into the CNS and causes neuroinflammation are not
fully understood. Our previous findings and other stud-
ies suggested that LPS is able to activate the immune
system by stimulation of monocytes, macrophages, neu-
trophils, blood platelets and endothelial cells [34, 35].
The activation of immune cells by LPS leads to release
of inflammatory cytokines that are responsible for pro-
gression of inflammatory reactions and may cross the
blood–brain barrier to mediate central effects. Thus, the
increased proinflammatory cytokines in the brain could
be derived from the activated MG, or from immune cells
which are activated by systemic LPS administration in
circulation, or both. In order to avoid the influence of
systemic inflammation on the brain, we adopted LPS (1
mg/kg) i.c.v. injection to establish the neuroinflamma-
tion model. At 6 h post LPS i.c.v. injection, compared
with that in untreated mice, the significantly increased
expression of TNF-α and IL-1β mRNA was found in
LPS-treated WT, CatCOE, and CatCKD mice by ISH
staining (Fig. 4A) and qRT-PCR analysis (Fig. 4B).
Among them, significantly higher expression was found
in CatCOE mice compared with that in WT mice. In
contrast, significantly alleviative expression was
Fig. 4 The effects of differential expression of CatC on M1 polarization of microglia in the brain. TNF-α ISH staining in cortex and hippocampus was
performed 24 h after LPS (1mg/kg, i.c.v.) injection (A). The levels of TNF-α and IL-1β were measured by qRT-PCR (B) and ELISA (D), respectively. The
activation of microglia in cortex and hippocampus was detected by Iba1 IHC staining (C). Scale bars, 200 μm (main panels, first and second rows),
500 μm (main panels, third row), 100 μm (main panels, fourth row), 50 μm (insets). *P≤ 0.05, **P≤ 0.01. n = 3(A, B), n = 3–5 (C, D)
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exhibited in CatCKD mice. Since the expression of
TNF-α and IL-1β are closely associated with classical ac-
tivation of MG (M1 phenotype), therefore, we evaluated
mRNA expressions of other M1 markers including IL-6,
CD86, CD16, and CD32 [36–38]. The mRNA expres-
sions of these markers were very similar to those of
TNF-α and IL-1β (Fig. 4B), suggesting that the inflam-
matory condition in CatCOE or CatCKD mice may be
associated with MG activation status. We next evaluated
the morphology of MG by Iba-1 IHC staining. As shown
in Fig. 4C, although activated MG were found in the
whole brain after LPS treatment, the most activated phe-
notypes of MG were found in CatCOE mice in both cor-
tex and hippocampus. Also, the highest expression levels
of TNF-α, IL-1β, and IL-6 protein were found in Cat-
COE mice, while the lowest level was found in CatCKD
mice after LPS treatment (Fig. 4D). Taken together, these
results suggested that CatC aggravated neuroinflamma-
tion induced by a central injection of LPS through ac-
centuating MG towards M1 polarization.
CatC increased production of proinflammatory factors
under LPS stimulation by accentuating MG towards M1
polarization
In order to confirm our speculation, we performed pri-
mary MG culture from WT, CatCOE, and CatCKD mice
and stimulated MG with LPS (50 ng/ml) for 24 h. We
first detected mRNA expression of M1 markers includ-
ing TNF-α, IL-1β, IL-6, CD86, CD32, and CD16. The re-
sults were very similar to those in in vivo, with the
highest levels exhibited in MG of CatCOE mice, while
the lowest in MG of CatCKD mice (Fig. 5A), suggesting
CatC accentuated MG towards M1 polarization after
LPS treatment. Then ELISA was carried out to detect
the expression of TNF-α and IL-1β protein in cell lysates
(Fig. 5B) and culture supernatants (Fig. 5C). The results
showed that the highest levels of IL-1β and TNF-α were
found in CatCOE MG in both cell lysates and culture
supernatants. In contrast, CatCKD MG exhibited the
lowest levels. These results further suggested that CatC
aggravated LPS-induced inflammation through accentu-
ating MG to M1 polarization in vivo.
CatC stimulation promoted MG towards M1 phenotype in
vitro and in vivo
It has been well known that LPS can activate MG and
promote them to polarize to M1 activation status, pro-
ducing proinflammatory factors and aggravating neuro-
inflammation [39–41]. In our present study, both in vivo
and in vitro results suggested that CatC enhanced MG
activation and production of IL-1β and TNF-α under
LPS stimulation. And more importantly, the mRNA ex-
pressions of M1 markers were upregulated in CatCOE
mice and cultured CatCOE MG while downregulated in
CatCKD mice and cultured CatCKD MG, suggesting
that CatC accentuated MG towards M1 polarization
under LPS stimulation. In our previous study, we re-
ported that CatC is expressed intracellularly and se-
creted extracellularly in MG following LPS stimulation
[17]. Therefore, we speculate whether exogenous CatC
Fig. 5 The effects of differential expression of CatC on M1 polarization of microglia in vitro. Primary cultured microglia from WT, CatCOE, and CatCKD
mice were stimulated with LPS (50 ng/ml) for 24 h. A The mRNA expressions of TNF-α, IL-1β, IL-6, CD86, CD32, and CD16 were measured by qRT-PCR.
B The levels of TNF-α and IL-1β in cellular lysate and culture supernatant were measured by ELISA. *P≤ 0.05, **P≤ 0.01, ****P≤ 0.0001
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can directly facilitate MG towards M1 activation status.
We used active CatC (10 ng/ml) to stimulate primary
cultured MG from WT mice. After 18 h stimulation, we
found that the mRNA expression of M1 markers for
MG including TNF-α, IL-1β, CD86, CD16, CD32, and
IL-6 were significantly elevated compared with that in
untreated MG by qPCR (Fig. 6A). We further used
CD86 and CD206 as the markers of M1 and M2 pheno-
types to perform flow cytometry analysis after exogenous
CatC stimulation of MG. The results showed that the
number of CD86 positive cells was increased signifi-
cantly in CatC-treated MG (Fig. 6B (a, b)). These results
suggested that exogenous CatC alone, independent of
LPS, could promote MG polarized towards M1 pheno-
type. In our previous study, we reported that LPS could
induce CatC expression in cultured MG, and it is known
that LPS is one of the inducers for M1 polarization, so
we wondered whether CatC-expressing MG was M1
phenotype. Therefore, we performed CD86 and CatC
double immunofluorescence staining in LPS-treated
MG, and untreated MG was used as the control
(Fig. 6C). As we expected, both CD86 and CatC-positive
MG were only found in LPS-treated MG, suggesting
CatC could not only promote MG towards M1 pheno-
type but also be produced by MG of M1 phenotype.
In order to confirm these results in vivo, we performed
CatC (10 ng/ml) i.c.v. injection, and equivolume 0.9% sa-
line vehicle injection mice were used as the control.
After 6-h treatment, total mRNA was isolated from the
whole brain, and mRNA expressions of aforementioned
M1 markers were detected by qRT-PCR (Fig. 6D). The
results showed that mRNA expression of all the markers
were significantly higher than that in control mice.
Taken together, in vivo and in vitro the results suggest
that exogenous CatC facilitate MG towards M1 activa-
tion status.
Exogenous CatC caused numerous gene expression
changes including NR2B which is the subunit of NMDA
receptors
So far, we have demonstrated that CatC can aggravate
neuroinflammation through inducing MG towards M1
phenotype. To identify the underlying molecular changes
of CatC promoting MG towards M1 phenotype,
microarray-based gene expression analysis was per-
formed on primary cultured WT MG stimulated with
active CatC (100 ng/ml, 12 h) for 24 h. After that, total
RNA was extracted, and the genomic expression profile
of CatC after MG treatment was analyzed. Microarray
hybridization signal scanning showed that fluorescence
signaling quality control was good, and the ratio of sig-
nal to noise was low (Data not shown). Hierarchical
cluster analysis of differentially expressed (DE) genes
showed that the genes ultimately clustered into two major
branches, indicating significant differences between un-
treated and CatC-treated MG. Results showed that there
were 254 DE genes in CatC-stimulated MG, including 103
upregulated genes and 151 downregulated genes. As
shown in Fig. 7A, the heat map includes 10 upregulated
genes and 15 downregulated genes. Upregulated genes are
shown in red and downregulated genes are in green. Com-
bining the results of GO (Gene Ontology) analysis, NR2B
was chosen as a molecule for in-depth study.
Therefore, we detected expression of NR2B in both
primary cultured MG and BV2 cells with CatC stimula-
tion. qRT-PCR results showed that the mRNA expres-
sion of NR2B was increased in CatC-treated primary
cultured MG (Fig. 7B (a)) and BV2 cells (Fig. 7C (a)).
The expression of phosphorylated NR2B (p-NR2B) and
total NR2B (t-NR2B) was also increased in CatC-treated
primary cultured MG (Fig. 7B (b, c)) and BV2 cells
(Fig. 7C (b, c)). Moreover, we inhibited CatC activity by
using cathepsins inhibitor E-64. Western blot analysis
showed that there was lowered tendency for expression
of p-NR2B and t-NR2B in E-64 and CatC co-incubated
primary cultured MG (Fig. 7B (b, c)) and BV2 cells
(Fig. 7C (b, c)) compared with that in CatC-treated
alone, which may be associated with inhibitory effects of
E-64 on CatC activity. These data suggest that exogen-
ous CatC stimulation increased the expression of acti-
vated NR2B.
CatC induced activation of Ca2+-dependent PKC/p38
MAPK/NF-κB signaling pathway in MG
NR2B is the regulation subunit of N-methyl-D-aspartate
receptors (NMDARs) which are ligand-gated ion channels
with high permeability to Ca2+ [42], a crucial intracellular
second messenger. Intracellular Ca2+ overload may acti-
vate a variety of intracellular signal transduction pathways
[43], including Ca2+-dependent PKC/p38 MAPK/NF-κB
cascades to induce MG activation, control a range of cel-
lular process, including chemotaxis, phagocytosis, and se-
cretion of cytokines.
In the present study, we have found that CatC promoted
MG towards M1 phenotype and the expression of NR2B.
To confirm that the effects of CatC on MG is mediated by
NMDAR-mediated Ca2+ signals, the intracellular Ca2+
concentration was measured by flow cytometry. As shown
in Fig. 8A, fluorescence of the Ca2+ indicator Fluo-3 AM
in CatC-treated BV2 cells was increased compared with
the control, and this response was reversed by addition of
E-64 and NMDAR antagonist MK-801, respectively
(Fig. 8A). The data indicate that the elevated Ca2+ levels in
the cytoplasm following CatC treatment was mediated by
NMDAR. Furthermore, western blot analysis showed that
CatC stimulation (100 ng/ml, 12 h) induced a significant
increase of PKC phosphorylation compared with the con-
trol in both primary cultured MG (Fig. 8B) and BV2 cells
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(Fig. 8C). In addition, the phosphorylation of p38 (Fig. 9A
(a), B (a)), IκBα (Fig. 9A (b), B (b)) and p65 (Fig. 9A (c), B
(c)), the key molecules of MAPKs/NF-κB pathway, were in-
creased in CatC-treated primary cultured MG (Fig. 9A) and
BV2 cells (Fig. 9B), while addition of E-64 and MK-801 re-
versed the phosphorylation of above molecules. Together,
the data suggest that CatC enhanced NR2B expression and
further induced the activation of Ca2+-dependent PKC/p38
MAPK/NF-κB pathway, leading to an increase in produc-
tion and release of proinflammatory cytokines in MG.
Discussion
In the present study, differential expression of CatC pro-
duced different effects on MG activation, cytokine ex-
pression and spatial learning, and memory in CatCOE,
CatCKD, and wild-type mice pre-treated with LPS cen-
trally or peripherally. CatC aggravated neuroinflamma-
tion by promoting MG polarization towards M1
phenotype. This effect is mainly achieved through activa-
tion of Ca2+-dependent PKC/p38 MAPK/NF-κB pathway
which is probably triggered by glutamate receptor sub-
unit NR2B. To the best of our knowledge, this is the first
study to demonstrate the possible molecular mecha-
nisms of CatC-involved neuroinflammation in the brain.
Chronic neuroinflammation is ubiquitous pathological
change in many neurological diseases, such as neurode-
generative diseases, and mood-related diseases. In these
diseases, inflammation responses present in a prolonged
and persistent pattern, leading to progressive changes of
the inflammatory process in neural tissues. The mecha-
nisms underlying maintenance of chronic neuroinflam-
mation remains unclear. It has been found that
chronically activated MG adversely secrete mediators to
promote inflammation and damage neurons. Microglia--
driven neuroinflammation has been confirmed to contrib-
ute to the progression of neurological diseases [44–46].
MG express and secrete several different cathepsins, a
large group of lysosomal proteases, to participate in the
key neuroinflammatory pathways and processes [47–53],
supporting various immune functions of MG [54]. CatC is
synthesized as inactive preprocathepsin C in vivo and is
processed into its active mature form by a series of pro-
teolytic cleavages. Some endopeptidases, presumably ca-
thepsin L or S, are responsible for the activation of CatC
[55]. Once activated, CatC mediates the conversion of
Fig. 7 The changes of expression of NR2B in CatC-stimulated microglia in vitro. Primary cultured microglia form WT mice were stimulated with
100 ng/ml active CatC for 24 h, then microarray-based gene expression analysis was performed. A The heat map showed 25 differentially
expressed genes, including 10 upregulated genes and 15 downregulated genes. B The mRNA expression of NR2B was verified by qRT-PCR with
100 ng/ml active CatC stimulation and/or cathepsin inhibitor E-64 (50μΜ) for 12 h (a). Phosphorylated NR2B (p-NR2B) and total NR2B (t-NR2B)
expressions were quantified in CatC-stimulated microglia by western blot analysis (b, c). C The same experiments were performed in BV2 cells.
GAPDH as a loading control. The data represent the increased folds of treatment groups relative to the control. The data represent mean ± SEM,
n = 3. *P < 0.05, **P < 0.01, ***P < 0.001
(See figure on previous page.)
Fig. 6 The effects of CatC stimulation on the expression of M1 markers of microglia in vitro. Primary cultured microglia from WT mice was
stimulated with active CatC (10 ng/ml) for 18 h. A The mRNA expressions of TNF-α, IL-1β, CD86, CD16, CD32, and IL-6 were measured by qRT-PCR.
B The percentages of CD86+ and CD206+ cells were measured by flow cytometry. C CD86 and CatC co-expression was detected by
immunofluorescent staining after LPS (50 ng/ml) treatment for 18 h. D The mRNA expressions of TNF-α, IL-1β, CD86, CD16, CD32, and IL-6 were
measured by qRT-PCR in mice with injection of CatC (0.43 mg/μl, i.c.v.) for 6 h. Scale bars, 25 μm. The data represent mean ± SEM, n = 3. *P < 0.05,
** P < 0.01, ****P < 0.0001
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granule serine proteases from their inactive (zymogen)
into the enzymatically active protease by removing an
N-terminal propeptide [10].
In the present study, CatC overexpression enhanced
MG towards M1 polarization, induced proinflammatory
cytokines expression in LPS-pretreated mice, and in
vitro CatC alone induced the same effects on MG
polarization. Our previous study found that the CatC
expression was increased in a dose-dependent manner
in lysates and medium of cultured MG treated with
LPS, IL-1β, or IL-6. Meanwhile, enzymatic activity of
CatC was also upregulated. These findings indicate that
inflammatory stimuli can induce the expression and re-
lease of CatC in MG. Herias et al. [20] reported that
CatC may exert immunomodulatory effects on macro-
phages through an autocrine positive feedback of CatC
in macrophage polarization towards M1 in atheroscler-
otic lesion. Collectively, this evidence strongly points to
a potential interaction between inflammatory cytokines
and CatC in MG, and such interactions contribute to
amplify cytokines and neuroinflammation-involved cel-
lular events, responsible for the continuous inflamma-
tory cycle accompanying pathogenesis in the CNS.
It should be noted that in the absence of exogenous
stimuli, differential expression of CatC did not affect
learning and memory ability or the expression of cyto-
kines, except that slight activation of MG was observed
in CatCOE mice. Overall, immune homeostasis was
maintained in vivo, regardless of CatC expression. How-
ever, upon immune activation, just like LPS injection in
the present study, CatC will enter inflammatory cycle to
further aggregate the inflammatory responses.
Fig. 8 CatC stimulation increased the concentration of intracellular Ca2+ and induced PKC activation. BV2 cells were stimulated with active CatC
(100 ng/ml) and co-stimulated with E-64 (50 μM) or pre-incubated with MK-801 (10 μM) for 6 h. Then, intracellular Ca2+ concentration was
measured by flow cytometry (A). Primary cultured microglia form WT mice and BV2 cells were stimulated with active CatC (100 ng/ml), or
co-stimulated with E-64 (50 μM), or treated with MK-801 (10 μM) prior to CatC stimulation for 12 h. The expressions of p-PKC and t-PKC were
quantified by western blot analysis in primary cultured microglia (B) and BV2 cells (C). The bands shown are representative of three independent
experiments. GAPDH as a loading control. The statistics are shown as increased folds of treatment groups to the control. The data represent
mean ± SEM, n = 3. *P < 0.05, **P < 0.01
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NMDAR is a heteromeric ligand-gated ion channel
that interacts with multiple intracellular proteins by way
of different subunits [56]. The functional NMDAR ex-
pression is detected in membrane fraction of MG, and
stimulation of NMDAR can trigger activation of MG
and secretion of inflammatory factors in vitro [57]. Also,
brain inflammation affects the expression of NMDAR in
the hippocampal areas [58]. These findings point to the
potential roles of NMDAR in MG-mediated inflamma-
tion. In our study, microarray-based gene expression
analysis revealed that CatC stimulation caused an in-
crease in mRNA expression of NMDAR subunit, NR2B.
Therefore, NR2B was selected to be a downstream ef-
fector gene following CatC treatment. NR2B has been
demonstrated to play unique/critical roles in determin-
ing the structural and functional properties of the
NMDAR. The changes in brain environment resulting
from kinases, phosphatases, and other regulatory en-
zymes can influence the expression, distribution, and
function of the NR2B subunit. The inflammatory stimuli
had been shown to promote NR2B expression in the
brain. Maher et al. [59] reported that NR2B is overex-
pressed in systemic LPS-induced AD model mice, and
increased NO concentration in the brain may contribute
to NR2B expressional upregulation. Harré et al. [60]
showed a pronounced long-term upregulation of NR2B
mRNA in the hippocampus and cortex of rats following
systemic LPS administration. Consistently, our study
also showed that LPS-treated MG produced a higher
level of NR2B mRNA compared to untreated cells (data
not shown). LPS is a well-documented strong inducer
for MG M1 polarization, and CatC has been proven to
have the same effect on MG. The fact that LPS and CatC
both enhanced NR2B transcripts in MG drives us to
suppose that the upregulation of NR2B transcript follow-
ing CatC treatment may be associated with increased
proinflammatory cytokine release derived from M1
phenotype of MG. Our data not only indicate that NR2B
is related to immune activation of MG, but also establish
the potential functional links between CatC and NR2B
Fig. 9 CatC activated p38 MAPK/NF-κB signaling pathway in microglia. A Primary cultured microglia from WT mice were treated with active CatC
(100 ng/ml), or co-stimulated with E-64 (50 μM), or pretreated with MK-801 (10 μM). The expressions of p-p38, t-p38, p-IκBα, t-IκBα, p-p65, and
t-p65 were quantified by western blot analysis. The levels of p-p38/t-p38 (a), p-IκBα/t-IκBα (b), p-p65/t-p65 (c) were shown as increased folds of
treatment groups relative to control group. B Activation of p38 MAPK/NF-κB signaling pathway was examined in BV2 cells. The bands shown are
representative of three independent experiments. The data represent mean ± SEM, n = 3. *P < 0.05, **P < 0.01
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in MG. However, how and whether CatC modulates dir-
ectly the functional expression of NR2B and further af-
fects receptor function in MG is yet to be understood.
NR2B subunit is composed of 1456 amino acids with
an approximate molecular mass of 170–180 kDa, pos-
sessing extracellular NH2-terminal signal peptide,
intracellular C-terminal domains and 4 putative trans-
membrane domains (M1–M4) [42, 61]. In the second
transmembrane region, an asparagine residue is the pu-
tative pore-forming region and play a role in the high
Ca2+ permeability of the channel. Previously, Murugan
et al. [62] reported that activated MG expressed func-
tional NMDAR. A notable increase in intracellular cal-
cium was observed after NMDAR activation in hypoxia,
which was significantly reduced by addition of MK801
(a NMDA channel blocker) in primary cultured MG.
Moreover, the hypoxia-induced activation of NF-κB sig-
naling pathway in MG was suppressed by administra-
tion of MK801. In our study, in primary cultured MG,
an increase in intercellular Ca2+ levels was blocked by
MK801, indicating potentiation of Ca2+ influx following
CatC treatment was mediated by NMDAR, most
probably by increased NR2B. The intracellular Ca2+
overload may induce PKC activation, leading to inflam-
matory response by activation of p38 MAPK-dependent
NF-ĸB pathway [44].
Conclusions
In conclusion, CatC induced NR2B expression in MG,
further activated Ca2+-dependent PKC/p38 MAPK/
NF-κB pathway, and promoted M1 polarization of MG,
leading to aggravation of neuroinflammation. The in-
teractions between CatC and inflammatory cytokines
in MG may be one of the main reasons of persistent
neuroinflammation in CNS. Our data suggest that
CatC may be one of key molecular targets for alleviat-
ing and controlling neuroinflammation in the neuro-
logical diseases.
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